Results 71 to 80 of about 96,183 (271)
Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials
Background The therapeutic efficacy of coenzyme Q10 on patients with cardiac failure remains controversial. We pooled previous clinical studies to re-evaluate the efficacy of coenzyme Q10 in patients with cardiac failure.
Li Lei, Yan Liu
doaj +1 more source
Development of nanoparticulate formulation of coenzyme Q10 and comparison of plasma coenzyme Q10 response in a single supplementation with regular coenzyme Q10 using rats [PDF]
Bioavailability of a nanoparticulate formulation of coenzyme Q10 (NQ20), which has high stability in the water phase, was evaluated. The particle size was 188 nm, and the zeta potential value was between -38.8 and -44.8 mV at 4, 25, and 40°C in distilled
권오란
core +1 more source
Therapeutic nano‐drug delivery systems interact with cellular mitochondria in a multitude of ways. While the complexity of such interactions disrupts the mitochondrial electron transport chain and increases reactive oxygen species production, thereby contributing to nanoparticle toxicity, they also present unique theranostic opportunities in diseases ...
Sourav Bhattacharjee
wiley +1 more source
Background: Chronic heart failure is a debilitating condition that accounts for an annual NHS spend of £2.3B. Low levels of endogenous coenzyme Q10 may exacerbate chronic heart failure. Coenzyme Q10 supplements might improve symptoms and slow progression.
Lindsay Claxton +14 more
doaj +1 more source
Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges.
World population growth and aging are posing unprecedented challenges in sustaining the health of 9.1 billion people that will be occupying the planet by 2050.
Marta Arenas-Jal +2 more
semanticscholar +1 more source
A low intake of selenium is associated with increased cardiovascular mortality. This could be reduced by supplementation with selenium and coenzyme Q10.
U. Alehagen +4 more
semanticscholar +1 more source
IGFBP4 is upregulated in granulosa cells of aged ovaries across monkeys, mice, and humans. It inhibits YAP signaling, thereby suppressing cell proliferation and contributing to follicular dysfunction. Deletion of Igfbp4 in granulosa cells enhances ovulatory output, improves hormone profiles, and reproductive performance in aged female mice, suggesting ...
Qianhui Hu +8 more
wiley +1 more source
Coenzyme-Q10 és obesitas kapcsolata [PDF]
Az obesitas napjaink egyik legnagyobb problémáját jelentő betegsége, mely egyre több embert érint. Napjainkig is rendkívül nehéz feladat az obesitas és kísérő betegségeinek kezelése, ezért folyamatos kutatasok folynak a lehetséges kiváltó okok, illetve ...
Kádár, Emese Lenke
core
Glaucoma, a major cause of blindness, involves retinal ganglion cell (RGC) degeneration. This study shows growth hormone‐releasing hormone receptor (GHRHR) deficiency preserves RGC survival and restores vision, unlike activation which only aids survival.
Yan Tong +24 more
wiley +1 more source
Effects of ubiquinone (coenzyme Q10) on myopathy in statin users. [PDF]
Item does not contain fulltextPURPOSE OF REVIEW: Statins are associated with muscle complaints, including myositis. The mechanism through which statin use causes muscle toxicity is unknown.
Schaars, C.F., Stalenhoef, A.F.H.
core +1 more source

